Affymetrix News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.03.16	ALDR Gains As Pain Wanes, APRI Disappoints, PBYI's NDA Filing Delayed Yet Again (RTTNews)
29.03.16	Affymetrix Reaffirms Support For Thermo Fisher Merger; Origin Withdraws Offer (RTTNews)
24.03.16	Affymetrix To Engage In Talks With Origin Technologies (RTTNews)
23.03.16	Thermo Fisher Says Origin's Offer Not Likely To Result In Superior Proposal (RTTNews)
23.03.16	Affymetrix Determines Offer From Origin Could Lead To Superior Proposal (RTTNews)
23.03.16	LLY Gets FDA Nod, MRK Scores Legal Win, AFFX Pursued By Origin Technologies (RTTNews)
23.03.16	Origin Technologies Raises Offer Price For Affymetrix To $17/shr (RTTNews)
22.03.16	Thermo Fisher Urges Affymetrix Stockholders To Vote In Favor Of Acquisition (RTTNews)
21.03.16	Affymetrix Under Pressure After Rejecting Origin Bid (RTTNews)
21.03.16	Origin Technologies Reiterates Its Offer For Affymetrix - Quick Facts (RTTNews)
21.03.16	AFFX Says No To Rival Bid, AUPH Awaits Data In Q3, Eagle Flies Down (RTTNews)
21.03.16	Affymetrix Rejects Origin Tech Offer, Supports Thermo Fisher Scientific Merger (RTTNews)
08.03.16	Affymetrix Receives Grant for Non-Invasive Genomic Profiling of Bladder Cancer (Businesswire)
17.02.16	EARNINGS SUMMARY: Details of Affymetrix Inc Q4 Earnings Report (RTTNews)
12.01.16	Bio-Genesys and Affymetrix Partner to Offer Animal Genomic Testing Services to Professional Farming Operations (Businesswire)
11.01.16	UPDATE/MÄRKTE USA/Zaghafte Käufer trauen sich in angeschlagenen Markt (Dow Jones)
11.01.16	MÄRKTE USA/Zaghafte Käufer trauen sich in angeschlagenen Markt (Dow Jones)
11.01.16	Thermo Fisher Scientific Inc. -- Thermo Fisher acquisition is credit negative; ratings unaffected (Moodys)
11.01.16	MÄRKTE USA/Wall Street startet mit leichter Erholung (Dow Jones)
09.01.16	Thermo Fisher Agrees To Buy Affymetrix For $1.3 Bln Cash (RTTNews)
28.10.15	Affymetrix Inc Q3 Earnings Rise 27% (RTTNews)
13.10.15	Enzo Biochem Announces Patent Infringement Settlement With Affymetrix (RTTNews)
29.07.15	EARNINGS SUMMARY: Details of Affymetrix Inc Q2 Earnings Report (RTTNews)
29.04.15	Affymetrix Results Top Estimates (RTTNews)
13.04.15	Affymetrix & MTI Unit Collaborate In Genetic Research - Quick Facts (RTTNews)
04.02.15	Affymetrix Profit Tops Estimates (RTTNews)
03.12.14	Affymetrix Announces Distribution Agreement With Binding Site (RTTNews)
01.12.14	Toshiba Selects Affymetrix Axiom Platform For Its Genotyping Service In Japan (RTTNews)
30.10.14	Affymetrix Results Top Estimate - Quick Facts (RTTNews)
20.10.14	Affymetrix Exclusively Licenses Technology from Peptide Groove LLP for HLA Typing from Genotyping Data (Businesswire)
17.10.14	AFFX In Harmony, SRPT, IBIO Focusing On Ebola, PCYC Inks Deal With Roche (RTTNews)
31.07.14	Affymetrix Q2 Loss Narrows - Quick Facts (RTTNews)
08.05.14	Affymetrix and Leica Biosystems Announce the Launch of Fully Automated RNA in situ Hybridization Assays (Businesswire)
01.05.14	Affymetrix Q1 Loss Narrows - Quick Facts (RTTNews)
05.02.14	Affymetrix Posts Q4 Profit - Quick Facts (RTTNews)
18.01.14	FDA Oks Post-natal Test To Detect Intellectual Disabilities In Children (RTTNews)
13.01.14	University of Bristol Collaborates with Affymetrix on Genotyping Arrays for Guaranteed Sustainability of Wheat Production (Businesswire)
07.01.14	Affymetrix Sees Q4 Revenues Above View - Quick Facts (RTTNews)
04.09.13	Empire Asset Management Company (CRD 143077) initiates coverage on AFFYMETRIX (NASDAQ:AFFX) with a buy rating. (PR Newswire)
15.08.12	Affymetrix gibt Ausdehnung der QuantiGene®-ViewRNA-Lizenz für In-vitro-Diagnostik bekannt und wird exklusiver Lizenznehmer für chromogene Anwendungen (Businesswire)
01.08.12	Affymetrix Announces Expansion of QuantiGene® ViewRNA License for in vitro Diagnostics and Becomes Exclusive Licensee for Chromogenic Applications (Businesswire)
07.06.12	Affymetrix und Leica Microsystems geben weltweite Zusammenarbeit bei automatischer In-Situ-Hybridisierung (ISH) der Single-Copy-RNA im Gewebe für Forschungszwecke bekannt (Businesswire)
06.06.12	Affymetrix Announces Research Collaboration with Massachusetts General Hospital to Validate and Develop New Oncology Biomarker Tests (Businesswire)
31.05.12	Affymetrix and Leica Microsystems Announce Worldwide Collaboration on Automated, Single-Copy, RNA In Situ Hybridization (ISH) Tissue Assay for Research Use (Businesswire)
25.05.12	Affymetrix und ScreenCell geben weltweiten Vertriebsvertrag über die Technologie für zirkulierende Tumorzellen (CTC) bekannt (Businesswire)
25.05.12	Affymetrix und ScreenCell geben weltweiten Vertriebsvertrag über die Technologie für zirkulierende Tumorzellen (CTC) bekannt (Businesswire)
17.05.12	Affymetrix and ScreenCell Announce Worldwide Distribution Agreement for Circulating Tumor Cell (CTC) Technology (Businesswire)
29.03.12	Affymetrix Announces a Global Distribution Agreement With Almac to Distribute Its Proprietary Xcel™ Array for Translational Research Applications (Businesswire)
23.02.12	Affymetrix Announces the Immediate Shipment of the New Axiom® Exome Genotyping Arrays (Businesswire)
16.02.12	China Clears Its First Microarray Platform for in Vitro Diagnostics to Accelerate Personalized Medicine (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	81.32	2.01 %	K V
Alcon	79.46	1.90 %	K V
Sonova Hldg	308.90	1.55 %	K V
ABB	51.64	1.29 %	K V
Lonza Grp	570.20	1.24 %	K V
Kuehne+Nagel Int	206.80	0.05 %	K V
Givaudan	3’960.00	-0.08 %	K V
Sika	227.00	-0.09 %	K V
Geberit	505.40	-0.20 %	K V
UBS Group	31.54	-0.66 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Affymetrix Inc.

Aktien Top/Flop

Meistgelesene Nachrichten